Korea's Celltrion Deepens Cooperation With PPD For Entire Biosimilar Portfolio

SEOUL - South Korea's biosimilar front-runner Celltrion Inc. signed a memorandum of understanding with contract research organization Pharmaceutical Product Development Inc. to expand their ongoing cooperation in clinical trials to Celltrion's seven remaining biosimilars as well as its future biologic development projects